Purple Biotech Ltd.: Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial
NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and neck cancer drugs pembrolizumab (Keytruda) or cetuximab ...
Analysts Set Bicara Therapeutics Inc. (NASDAQ:BCAX) Price Target at $41.20
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight ...
Monthly Prescribing Reference17h
Study Investigates Whether and When to Stop Metformin in Advanced CKD
Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.
Official Charts Company12h
The Official Charts
Welcome to the UK's Official Charts! In addition to the Official Singles and Albums Chart, did you know the Official Charts Company compiles 50+ charts every week, spanning different genres and ...